Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal M. Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
130
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Nautilus Biotechnology Inc market cap is $270.03M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nautilus Biotechnology Inc 52 week high is $4.31 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nautilus Biotechnology Inc 52 week low is $0.8411 as of November 22, 2026.
Nautilus Biotechnology Inc stock price today is $2.12.
Nautilus Biotechnology Inc stock price yesterday was $2.17.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Nautilus Biotechnology Inc's P/E ratio is -4.59.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Nautilus Biotechnology Inc P/B ratio is 2.3159.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Nautilus Biotechnology Inc 50-day moving average is $2.00.